Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356363/
https://www.ncbi.nlm.nih.gov/pubmed/37476339
http://dx.doi.org/10.1155/2023/9876715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356363/
https://www.ncbi.nlm.nih.gov/pubmed/37476339
http://dx.doi.org/10.1155/2023/9876715

Ejemplares similares